Red blood cells may hold key to heart attack risk in diabetes

NCT ID NCT07151222

Recruiting now Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study investigates how red blood cells influence heart attack risk in people with type 2 diabetes. Researchers will collect blood from 500 participants (patients with heart attacks, type 2 diabetes, and healthy volunteers) and test the cells in the lab to understand their effects on heart and blood vessel function. The goal is to uncover new ways to prevent heart damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new treatments that target red blood cells to reduce heart attack risk in people with type 2 diabetes.
What could go wrong: This is an early-stage, observational study using lab tests, not a treatment trial. It may not lead to any new therapies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS

Contacts and locations

Locations

Karolinska Institutet
RECRUITING

Stockholm, Swsden, 17176, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.